English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

With an estimated 570,000 new cases and 311,000 deaths in 2018, cervical cancer is the second most common female malignancy worldwide; 1 in 75 women develop cervical cancer during a lifetime (1). In China, cervical cancer is the second leading cause of cancer death among women, and there were over 102,000 new cases and 30,000 deaths in 2014 (2), making it a major public health problem. Approximately two-thirds of patients in developing countries have locally advanced stage disease at diagnosis, Original Article

Prognosis of stage III cervical cancer: a two-way outcome study